Phase I Study of ICP-332 in Healthy Subjects

Clinical trial NCT06530966 · COMPLETED

Trial details

NCT number: NCT06530966
Sponsor: InnoCare Pharma Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects

Start date: 2024-07-23
Primary completion: 2024-11-08
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.